Literature DB >> 1573751

Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients.

S W Dooley1, M E Villarino, M Lawrence, L Salinas, S Amil, J V Rullan, W R Jarvis, A B Bloch, G M Cauthen.   

Abstract

OBJECTIVE: To assess nosocomial transmission of tuberculosis (TB).
DESIGN: A historical cohort study of hospitalized patients with the human immunodeficiency virus (HIV) and a purified protein derivative (PPD) tuberculin skin test survey of health care workers (HCWs).
SETTING: A large public teaching hospital in San Juan, Puerto Rico. PATIENTS: For the cohort study, a case patient was defined as any patient in the HIV unit at the hospital who developed culture-positive TB from 31 days or more after admission through December 31, 1989. For the PPD survey, of 1420 HCWs from the hospital, 908 agreed to participate and had sufficient data for analysis. MAIN OUTCOME MEASURES: For the cohort study, to compare the risk of developing active TB among patients who were exposed to hospital roommates with infectious TB and the risk among nonexposed patients. For the HCW PPD survey, to determine the prevalence of and risk factors for tuberculous infection.
RESULTS: Eight of 48 (9.7/10,000 person-days) exposed case patients vs four of 192 (0.8/10,000 person-days) nonexposed case patients developed active TB (relative risk [RR] = 11; 95% confidence interval [CI], 2.3, 50.3). Positive PPDs (greater than or equal to 10 mm of induration) in HCWs were associated with older age (P = .0001) and with history of community TB exposure (P = .0002). In a multivariable logistic model that adjusted for these variables, HIV unit nurses (nine of 19) and nurses in the internal medicine ward (45 of 90) had a higher proportion of positive PPDs than the reference group (clerical personnel on other floors: 35 of 188, P = .0005).
CONCLUSIONS: These data suggest that patient-to-patient transmission of TB in HIV units can occur and that HCWs are at risk of acquiring TB infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1573751

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  38 in total

1.  The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis.

Authors:  M E Villarino; L J Geiter; P M Simone
Journal:  Public Health Rep       Date:  1992 Nov-Dec       Impact factor: 2.792

2.  Screening and treatment of immigrants and refugees to Canada for tuberculosis: Implications of the experience of Canada and other industrialized countries.

Authors:  R E Thomas; B Gushulak
Journal:  Can J Infect Dis       Date:  1995-09

3.  Secondary typing of Mycobacterium tuberculosis isolates with matching IS6110 fingerprints from different geographic regions of the United States.

Authors:  Z H Yang; J H Bates; K D Eisenach; M D Cave
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  On methods for studying stochastic disease dynamics.

Authors:  M J Keeling; J V Ross
Journal:  J R Soc Interface       Date:  2008-02-06       Impact factor: 4.118

5.  The scourge of tuberculosis revisited.

Authors:  J Conly; S Shafran
Journal:  Can J Infect Dis       Date:  1995-11

6.  Detection of acid-fast bacilli in concentrated primary specimen smears stained with rhodamine-auramine at room temperature and at 37 degrees C.

Authors:  Y S McCarter; A Robinson
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

7.  Differentiation of Mycobacterium tuberculosis isolates by spoligotyping and IS6110 restriction fragment length polymorphism.

Authors:  M Goyal; N A Saunders; J D van Embden; D B Young; R J Shaw
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

8.  Evaluation and utilization as a public health tool of a national molecular epidemiological tuberculosis outbreak database within the United Kingdom from 1997 to 2001.

Authors:  F A Drobniewski; A Gibson; M Ruddy; M D Yates
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania.

Authors:  Z H Yang; I Mtoni; M Chonde; M Mwasekaga; K Fuursted; D S Askgård; J Bennedsen; P E de Haas; D van Soolingen; J D van Embden
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

Review 10.  New developments in tuberculosis and HIV infection: an opportunity for prevention.

Authors:  J R Curtis; T M Hooton; C M Nolan
Journal:  J Gen Intern Med       Date:  1994-05       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.